Skip to main content

Advertisement

Figure 4 | Malaria Journal

Figure 4

From: Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

Figure 4

Parasite cross-reactivity of anti-GMZ2 IgG responses. Immune sera of differentially-formulated NMRI mice were tested for parasite binding in IFA (a) with in vitro cultured P. falciparum blood stage parasites and Western blot analysis (b, c) with parasite lysate. Shown are endpoint titres observed with sera of individual animals, the horizontal lines are representing the geometric mean.

Back to article page